117 related articles for article (PubMed ID: 2051981)
21. [The immune defense system in gastric cancer tissue, regional lymph node and spleen--aspects from subsets and functions of lymphocytes].
Tanaka N; Gohchi A; Akura Y; Gotoh K; Okabayashi T; Horimi T; Orita K
Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1112-5. PubMed ID: 4088222
[TBL] [Abstract][Full Text] [Related]
22. [Distribution of lymphocyte subsets in regional lymph nodes in uterine cervical cancer and its immunological significance].
Kinugasa M; Akahori T; Mochizuki M; Hasegawa K
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Apr; 43(4):383-90. PubMed ID: 2066610
[TBL] [Abstract][Full Text] [Related]
23. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
24. The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients.
Gochi A; Orita K; Fuchimoto S; Tanaka N; Ogawa N
Br J Cancer; 2001 Feb; 84(4):443-51. PubMed ID: 11207036
[TBL] [Abstract][Full Text] [Related]
25. [Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].
Hosokawa T
Nihon Geka Gakkai Zasshi; 1991 May; 92(5):577-86. PubMed ID: 1831533
[TBL] [Abstract][Full Text] [Related]
26. [Intratumoral injection of biological response modifier (BRM)].
Nishiyama K
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1225-8. PubMed ID: 1944192
[TBL] [Abstract][Full Text] [Related]
27. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
[TBL] [Abstract][Full Text] [Related]
28. [T-and B-cell immune response of lymph nodes and immunosuppression correlating with metastatic spread of stomach cancer].
Bugrov VV; Absaliatova OV; Savkova RF; Kozlova NM
Vopr Onkol; 2008; 54(2):216-9. PubMed ID: 18522173
[TBL] [Abstract][Full Text] [Related]
29. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
Akimoto M; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
[TBL] [Abstract][Full Text] [Related]
30. [Immunohistochemical study of the regional lymph nodes in gastric cancer].
Okabayashi T
Nihon Geka Gakkai Zasshi; 1987 May; 88(5):529-42. PubMed ID: 3110588
[TBL] [Abstract][Full Text] [Related]
31. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
32. [Changes in cytokine levels in ascitic fluid after intraperitoneal administration of OK-432].
Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1443-5. PubMed ID: 8373202
[TBL] [Abstract][Full Text] [Related]
33. [Distribution of lymphocyte subpopulation and natural killer activity in gastric cancer tissue, normal stomach and various tissues of gastric cancer patients].
Moritani Y
Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):132-42. PubMed ID: 6611484
[TBL] [Abstract][Full Text] [Related]
34. [Correlation of involved lymph nodes in stomach cancer with immunologic characteristics of the host and of the tumor].
Bugrov VV; Absaliamova OV
Vopr Onkol; 2003; 49(4):442-4. PubMed ID: 14569933
[TBL] [Abstract][Full Text] [Related]
35. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
Akimoto M; Nishihira T; Kasai M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1270-6. PubMed ID: 3729450
[TBL] [Abstract][Full Text] [Related]
36. [Metastatic behavior of footpad-inoculated tumors in mice and the impact of OK-432 per os administration].
Nakajima Y; Akimoto M; Kimura M; Iwasaki H; Matano S; Hirakawa H; Mori S
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1229-33. PubMed ID: 3579323
[TBL] [Abstract][Full Text] [Related]
37. [Effect of injecting activated carbon ultramicroparticles around the gastric tumor on staining lymph node].
Huang GJ; Chen ZQ; Zhang YL; Zhang QH; Liu Y; Qian LP; Chen J; Ni QX
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2070-2. PubMed ID: 15730618
[TBL] [Abstract][Full Text] [Related]
38. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
40. [Influence of OK 432 upon postoperative alteration in activities producing lymphokines, IL 1, IL 2, and IFN, of peripheral blood mononuclear cells derived from patients with gastric cancer].
Hosoi J
Nihon Gan Chiryo Gakkai Shi; 1987 Apr; 22(3):603-13. PubMed ID: 2443588
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
